- Home
- FF vs THRD Comparison
FF vs THRD Comparison
Compare FF & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FF
- THRD
- Stock Information
- Founded
- FF N/A
- THRD 2019
- Country
- FF United States
- THRD United States
- Employees
- FF N/A
- THRD 53
- Industry
- FF Major Chemicals
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- FF Industrials
- THRD Health Care
- Exchange
- FF Nasdaq
- THRD Nasdaq
- Market Cap
- FF 172.1M
- THRD 164.2M
- IPO Year
- FF N/A
- THRD 2022
- Fundamental
- Price
- FF $3.94
- THRD $5.16
- Analyst Decision
- FF Strong Buy
- THRD Hold
- Analyst Count
- FF 1
- THRD 3
- Target Price
- FF $0.80
- THRD $5.00
- AVG Volume (30 Days)
- FF 504.5K
- THRD 1.1M
- Earning Date
- FF 05-08-2025
- THRD 05-14-2025
- Dividend Yield
- FF 6.06%
- THRD N/A
- EPS Growth
- FF N/A
- THRD N/A
- EPS
- FF 0.35
- THRD N/A
- Revenue
- FF $243,339,000.00
- THRD N/A
- Revenue This Year
- FF N/A
- THRD N/A
- Revenue Next Year
- FF N/A
- THRD N/A
- P/E Ratio
- FF $11.26
- THRD N/A
- Revenue Growth
- FF N/A
- THRD N/A
- 52 Week Low
- FF $3.77
- THRD $3.18
- 52 Week High
- FF $6.40
- THRD $16.94
- Technical
- Relative Strength Index (RSI)
- FF 41.85
- THRD 80.42
- Support Level
- FF $3.86
- THRD $3.30
- Resistance Level
- FF $4.05
- THRD $5.15
- Average True Range (ATR)
- FF 0.22
- THRD 0.16
- MACD
- FF 0.01
- THRD 0.24
- Stochastic Oscillator
- FF 30.91
- THRD 99.47
About FF FutureFuel Corp. Common shares
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.